Paeds Cases · paediatric-dermatology
A child with bruising and a low platelet count — long case
Long-case and structured-discussion OSCE on a four-year-old boy with sudden bruising, petechiae and a platelet count of 10 × 10⁹ per litre: the sick-versus-well triage, the full-blood-count and film workup that confirms immune thrombocytopenia and excludes leukaemia, the ASH 2019 risk-based management from observation through corticosteroids or intravenous immunoglobulin, the safety-netting for intracranial haemorrhage, the recognition of IgA vasculitis and the safeguarding assessment of bruising with the TEN-4 FACES pattern.
On this page
Study tools
Target exams
Candidate instructions (10-minute long-case discussion)
You are the paediatric registrar in the emergency department. A previously well four-year-old boy presents with three days of increasing bruising over the limbs, a petechial rash over the ankles, and two episodes of epistaxis. He is afebrile, active and cheerful, with no hepatosplenomegaly or lymphadenopathy. His full blood count shows a haemoglobin of 124 g per litre, a white-cell count of 7.2 × 10⁹ per litre, a neutrophil count of 3.1 × 10⁹ per litre, and a platelet count of 10 × 10⁹ per litre, with a normal film showing no blasts. The examiner asks you to discuss the triage, the diagnosis and the exclusion of leukaemia, the management, the safety-netting, and the safeguarding assessment of his bruising. [3]
Your tasks are: [3]
- Outline the triage of this child and how the sick-versus-well split directs your pathway. [2]
- State the diagnosis and explain how you confirm it and exclude leukaemia. [3]
- Outline the management, including when you would treat and with what, and the safety-netting for serious bleeding. [1]
- Discuss how you would apply the safeguarding assessment to a bruising presentation, and what would change the picture to IgA vasculitis. [12]
You are not expected to manage refractory or chronic ITP independently — haematology is involved — but you should explain the first-line approach and the indications for referral. [2]
References6ShowHide
- [1]Provan D; Arnold DM; Bussel JB; et al Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv, 2019.PMID 31770441
- [2]Neunert C; Terrell DR; Arnold DM; et al American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv, 2019.PMID 31794604
- [3]Rodeghiero F; Stasi R; Gernsheimer T; et al Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 2009.PMID 19005182
- [4]Grace RF; Lambert MP; et al An update on pediatric ITP: differentiating primary ITP, IPD, and PID. Blood, 2022.PMID 34479363
- [5]Ozen S; Pistorio A; Iusan SM; et al EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis, 2010.PMID 20413568
- [12]Pierce MC; Kaczor K; Aldridge S; et al Bruising characteristics discriminating physical child abuse from accidental trauma. Pediatrics, 2010.PMID 19969620